Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New formulation of RotaTeq in healthy infants
2012-001611-23Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of rotavirus vaccine, live, oral, pentavalent in rotaviral diarrhea (2 arms), sponsored by Merck & Co. Primary endpoint: Geometric mean titer of vaccine-induced serum neutralizing antibody to human rotavirus serotype G1. Started Jul 2012; status: completed.
02
Drugs
rotavirus vaccine, live, oral, pentavalent
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on 2012-001611-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001611-23.